cyclin D2 ; Homo sapiens






135 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
101 29421751 Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway. Chemosphere 2018 May 1
102 29472861 1,2,3,4,6-Penta-<i>O</i>-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression. Front Pharmacol 2018 1
103 30021382 MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells. Biomed Pharmacother 2018 Sep 4
104 30068546 PTE, a novel module to target Polycomb Repressive Complex 1 to the human cyclin D2 (<i>CCND2</i>) oncogene. J Biol Chem 2018 Sep 14 2
105 30106753 A novel hedgehog inhibitor for the treatment of hematological malignancies. Anticancer Drugs 2018 Nov 1
106 30127911 MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma. Oncol Lett 2018 Sep 1
107 30193733 Ploidy-dependent change in cyclin D2 expression and sensitization to cdk4/6 inhibition in human somatic haploid cells. Biochem Biophys Res Commun 2018 Sep 26 1
108 30308939 Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target. Int J Mol Sci 2018 Oct 10 2
109 30357839 LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. J Pathol 2019 Feb 1
110 30776175 Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers. Cancer Sci 2019 Apr 1
111 30925453 lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. Mol Ther Nucleic Acids 2019 Jun 7 2
112 31084542 Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells. J Med Food 2019 May 1
113 31432162 Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth. Mol Med Rep 2019 Oct 3
114 31571495 Belinostat suppresses cell proliferation by inactivating Wnt/β-catenin pathway and promotes apoptosis through regulating PKC pathway in breast cancer. Artif Cells Nanomed Biotechnol 2019 Dec 1
115 31610501 Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells. Environ Pollut 2019 Dec 1
116 32126144 Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. Blood Adv 2020 Mar 10 1
117 32170005 Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility. J Med Genet 2020 Oct 2
118 32184020 Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells. Biochem Biophys Res Commun 2020 May 14 3
119 32700749 miR‑135b‑5p enhances the sensitivity of HER‑2 positive breast cancer to trastuzumab via binding to cyclin D2. Int J Mol Med 2020 Oct 3
120 32791147 CircRSF1 contributes to endothelial cell growth, migration and tube formation under ox-LDL stress through regulating miR-758/CCND2 axis. Life Sci 2020 Oct 15 1
121 32820798 CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells. Biosci Rep 2021 Aug 27 1
122 33138842 DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma. Clin Epigenetics 2020 Nov 2 1
123 33436648 Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer. Sci Rep 2021 Jan 12 1
124 33480613 Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3. Chin Med J (Engl) 2021 Jan 20 1
125 33608112 LncRNA PRNCR1 Promotes Breast Cancer Proliferation and Inhibits Apoptosis by Modulating microRNA-377/CCND2/MEK/MAPK Axis. Arch Med Res 2021 Jul 1
126 33690729 Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. PLoS One 2021 1
127 33764958 Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells. Med Sci Monit 2021 Mar 25 1
128 33844344 Circ_0093887 upregulates CCND2 and SUCNR1 to inhibit the ox-LDL-induced endothelial dysfunction in atherosclerosis by functioning as a miR-876-3p sponge. Clin Exp Pharmacol Physiol 2021 Aug 2
129 34223793 Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction. Cell Cycle 2021 Jul 3
130 34303663 The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells. Eur J Pharmacol 2021 Oct 5 1
131 34314383 Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling. Aging (Albany NY) 2021 Jul 27 1
132 34746018 LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 <i>via</i> miR-206. Front Oncol 2021 5
133 34923957 Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway. Cancer Cell Int 2021 Dec 19 1
134 35159107 Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo. Cancers (Basel) 2022 Feb 8 2
135 35265169 Long Noncoding RNA LOC554202 Predicts a Poor Prognosis and Correlates with Immune Infiltration in Thyroid Cancer. Comput Math Methods Med 2022 1